LICENSE AGREEMENTLicense Agreement • November 9th, 2017 • Biotime Inc • Biological products, (no disgnostic substances) • California
LICENSE AGREEMENT (this “Agreement”) dated August 17, 2017 (the “Effective Date”) by and between BioTime, Inc,, a corporation incorporated under the laws of the State of California, United States of America (“BioTime”), and AgeX Therapeutics, Inc., a corporation incorporated under the laws of the State of Delaware, United States of America (“AgeX”) (each, a “Party” and, collectively, the “Parties”).
ASSET CONTRIBUTION AND SEPARATION AGREEMENTAsset Contribution and Separation Agreement • November 9th, 2017 • Biotime Inc • Biological products, (no disgnostic substances) • Delaware
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
